Pharmaceutical Contract Development and Market contains market size and forecasts of Pharmaceutical Contract Development and Manufacturing in Global, including the following market information:
- Global Pharmaceutical Contract Development and Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Pharmaceutical Contract Development and Manufacturing market was valued at 124880 million in 2021 and is projected to reach US$ 189210 million by 2028, at a CAGR of 6.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmaceutical Manufacturing Services Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Contract Development and Manufacturing include Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group and Consort Medical plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmaceutical Contract Development and Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Contract Development and Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, by Type, 2021 (%)
- Pharmaceutical Manufacturing Services
- Biologics Manufacturing Services
- Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, by Application, 2021 (%)
- Big Pharma
- Small Pharma
- Generic Pharma
- CRO
Global Pharmaceutical Contract Development and Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Pharmaceutical Contract Development and Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Pharmaceutical Contract Development and Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific Inc.
- Catalent, Inc.
- Lonza Group Ltd
- Recipharm AB
- Vetter Pharma International GMBH
- FAMAR Health Care Services
- AbbVie Inc.
- Aenova Group
- Consort Medical plc
- Almac Group
- Siegfried Holding AG
- Boehringer Ingelheim International GmbH
- Evonik Industries AG
Industry Market Size
